| commit | a603c2382ffcc49f344eee73dfcd65aa2332f64f | [log] [tgz] |
|---|---|---|
| author | tedx <tedx@google.com> | Tue Apr 19 12:04:07 2022 -0700 |
| committer | Copybara-Service <copybara-worker@google.com> | Tue Apr 19 12:05:59 2022 -0700 |
| tree | 79c43811cdfc1d03c5157e61bd636137030a040d | |
| parent | 16c4076cd39f43f3ccabbdeb6ab407c2063b038c [diff] |
Automated rollback of commit b93f828133e74cb3589ba7ffcfe74d2fe72430cd. *** Reason for rollback *** Breaks a subset of //src/test/java/com/google/devtools/build/android/r8:AllTests. See b/229725674 *** Original change description *** Switch to using the d8 jar from maven.google.com instead of the jar from the Android SDK. Also fixes #13989 RELNOTES: Bazel uses the D8 jar from Maven instead of the SDK. PiperOrigin-RevId: 442875035
{Fast, Correct} - Choose two
Build and test software of any size, quickly and reliably.
Speed up your builds and tests: Bazel rebuilds only what is necessary. With advanced local and distributed caching, optimized dependency analysis and parallel execution, you get fast and incremental builds.
One tool, multiple languages: Build and test Java, C++, Android, iOS, Go, and a wide variety of other language platforms. Bazel runs on Windows, macOS, and Linux.
Scalable: Bazel helps you scale your organization, codebase, and continuous integration solution. It handles codebases of any size, in multiple repositories or a huge monorepo.
Extensible to your needs: Easily add support for new languages and platforms with Bazel's familiar extension language. Share and re-use language rules written by the growing Bazel community.
Follow our tutorials:
To report a security issue, please email security@bazel.build with a description of the issue, the steps you took to create the issue, affected versions, and, if known, mitigations for the issue. Our vulnerability management team will respond within 3 working days of your email. If the issue is confirmed as a vulnerability, we will open a Security Advisory. This project follows a 90 day disclosure timeline.
See CONTRIBUTING.md
